
Henry Schein Reaches $13.2 Billion In Sales Amid Strategic BOLD+1 Expansion
Henry Schein, Inc.Description
What this story covers
Henry Schein reported $13.2 billion in 2025 net sales, driven by its BOLD+1 strategy. Despite supply chain risks and a 2026 CEO transition, the company maintains steady growth through global distribution, specialty manufacturing, and high-margin healthcare technology solutions.
Story snapshot
CompanyHenry Schein, Inc.
TickerHSIC
VariantStandard detailed
Duration11:33
Filing type10-K
PeriodAnnual 2025
IndustryHealthcare & Pharmaceuticals
Accession0001000228-26-000013
Sources1
Full Story Script
Content not available for this story.